Clinical Trials

200 enrolled 16 charts

HER2-positive Early Breast Cancer

NCT05415215 2026-02-10

ProHer

346 enrolled 20 charts

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT00314405 2025-12-22

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

100 enrolled

Breast Neoplasms

NCT02364557 2025-10-15

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

Phase 2/3 Completed

129 enrolled 23 charts

Breast Neoplasms, Lymphatic Metastasis

NCT06666517 2025-03-13

PERICAFS

69 enrolled

Breast Neoplasms

NCT04109066 2025-01-08

CheckMate 7FL

521 enrolled 17 charts

Breast Neoplasms, Neoplasms

NCT00182728 2024-10-01

NRR

89 enrolled 10 charts

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01015625 2024-08-19

POSYTIVE

90 enrolled 16 charts

Breast Neoplasms, Neoplastic Cells, Circulating

NCT03493854 2024-06-26

FeDeriCa

500 enrolled 28 charts 3 FDA

Breast Neoplasms

NCT04629846 2024-04-19

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

517 enrolled

Breast Neoplasms

NCT03272477 2024-04-17

TP-II

257 enrolled

Breast Neoplasms

NCT02620280 2024-03-06

NeoTRIPaPDL1

278 enrolled

Carcinoma, Ductal, Breast, Triple Negative Breast Neoplasms

NCT02636582 2023-12-05

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

43 enrolled 10 charts

Carcinoma, Intraductal, Noninfiltrating

NCT02586025 2023-05-22

PEONY

329 enrolled 33 charts

Breast Neoplasms

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

320 enrolled

Breast Neoplasms

NCT03916744 2023-03-10

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Phase 1 Completed

75 enrolled 24 charts

Breast Neoplasms

NCT04436744 2023-02-02

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

221 enrolled 21 charts

Breast Neoplasms

NCT01847001 2021-09-10

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

10 enrolled 12 charts

Breast Neoplasms

NCT00309569 2020-10-14

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

429 enrolled

Breast Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Phase 1/2 Completed

55 enrolled 10 charts

Breast Neoplasms

NCT00193778 2020-10-08

Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation

350 enrolled

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT02900469 2020-08-21

Presurgical Trial of Denosumab in Breast Cancer

44 enrolled

Breast Neoplasms

NCT03183206 2020-07-13

Safety and Efficiency of γδ T Cell Against Breast Cancer

Phase 1/2 Completed

100 enrolled

Breast Neoplasms

NCT00262834 2020-02-19

Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer

54 enrolled 7 charts

Breast Neoplasms

NCT02125630 2019-07-31

Bone Metastasis and Surgery in Breast Cancer

Completed

460 enrolled

Breast Neoplasms

NCT00675259 2018-07-24

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

33 enrolled 10 charts

Breast Neoplasms

NCT00944047 2018-04-23

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

32 enrolled 7 charts

Breast Neoplasms

NCT01142778 2018-03-16

AVATAXHER

152 enrolled

Breast Neoplasms

NCT01009437 2017-12-05

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Phase 1 Completed

28 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT00450723 2017-02-07

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

39 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00003050 2014-05-22

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

46 enrolled

Breast Neoplasms

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

101 enrolled 16 charts

Breast Neoplasms

NCT00842465 2013-11-25

Prolacsein

Completed

735 enrolled

Breast Diseases, Breast Neoplasms, Cystic Fibrosis

NCT00003953 2013-01-28

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

39 enrolled

Breast Neoplasms

NCT00016406 2013-01-24

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

399 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

45 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003035 2011-03-24

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

40 enrolled

Breast Neoplasms

NCT00191789 2010-07-27

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

65 enrolled 13 charts

Breast Neoplasms

NCT00161980 2006-10-23

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites